Compare DoorDash Inc (DASH) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DoorDash Inc vs Johnson & Johnson — how do they compare? DoorDash Inc trades at $212.2 (market cap $91.86B), while Johnson & Johnson trades at $258 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 6.8× DoorDash Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while DoorDash Inc pays none. Which is the better fit depends on your goals.
| DASH | JNJ | |
|---|---|---|
Market Cap | $91.86B | $626.09B |
Sector | Consumer Cyclical | Health |
52-Week High | $281.74 | $267.24 |
52-Week Low | $146.60 | $172.78 |
Enterprise Value | $89.82B | $654.37B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DoorDash (DASH) trades at $209.86, down 2.96% today, amid mixed earnings results but strong revenue growth. The stock shows a bullish technical trend above key support levels, with a 75.68% analyst buy rating. Recent Q2 2026 revenue beat expectations, though EPS missed due to higher R&D costs, while the company projects robust Q3 growth and continues investing in AI and autonomous delivery.
Outlook remains positive driven by expanding market share and profitability, but risks include intense competition and cost pressures. The consensus price target of $247.41 suggests ~18% upside, supported by solid cash flow and strategic acquisitions, though valuation multiples are elevated.
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DoorDash Inc
Founded in 2013 and headquartered in San Francisco, DoorDash is an online food order demand aggregator. Consumers can use its app to order food on-demand for pickup or delivery from merchants mainly in the U.S. The firm provides a marketplace for the merchants to create a presence online, market their offerings, and meet demand by making the offerings available for pickup or delivery. The firm provides similar service to businesses in addition to restaurants, such as grocery, retail, pet supplies, and flowers. At the end of 2020, DoorDash had over 450,000 merchants, 20 million consumers, and over 1 million dashers on its platform. In 2020, the firm generated $24.7 billion in gross order volume (up 207% year over year) and $2.9 billion in revenue (up 226%).
Read more on DASH →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
